New research explores the urea cycle’s strong connection to fatty liver disease
An Indiana University School of Medicine physician scientist is making strides in understanding the molecular origins of fatty liver disease,…
An Indiana University School of Medicine physician scientist is making strides in understanding the molecular origins of fatty liver disease,…
The most common chronic liver disease—called metabolic dysfunction–associated steatotic liver disease (MASLD)—is characterized by an increased buildup of fat in…
New research conducted in mice offers insights into what’s going on at the molecular level that could cause people with…
Ozempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with…